Yair Granot
Algemeen Directeur bij Curesign Ltd
Profiel
Yair Granot is currently the Chief Executive Officer at Curesign Ltd.
Previously, he worked as the Chief Executive Officer & VP-Development at Silver Castle Holdings Ltd.
and as the Chief Technology Officer at Essence Healthcare Ltd.
He holds a doctorate degree from the University of California, Berkeley and a graduate degree from Tel-Aviv University.
Actieve functies van Yair Granot
Bedrijven | Functie | Begin |
---|---|---|
Curesign Ltd
Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Algemeen Directeur | - |
Eerdere bekende functies van Yair Granot
Bedrijven | Functie | Einde |
---|---|---|
Essence Healthcare Ltd. | Hoofd Techniek/Wetenschap/O&O | - |
SILVER CASTLE HOLDINGS LTD | Algemeen Directeur | - |
Opleiding van Yair Granot
University of California, Berkeley | Doctorate Degree |
Tel-Aviv University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SILVER CASTLE HOLDINGS LTD | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Essence Healthcare Ltd. | |
Curesign Ltd
Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Health Technology |